Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart

Elina Minami1, Michael A Laflamme, Jeffrey E Saffitz

  • 1Division of Cardiology, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.

Circulation
|November 9, 2005
PubMed

Insights

Extracardiac progenitor cells repopulate heart cells after transplantation, with endothelial cells showing the highest integration. This early and extensive endothelial chimerism may impact graft health and rejection.

Area of Science:

  • Cardiovascular Biology
  • Transplantation Immunology
  • Stem Cell Biology

Background:

  • Extracardiac progenitor cells can integrate into the heart post-injury, but their extent in human heart transplants is unclear.
  • Previous studies showed limited cardiomyocyte repopulation by these cells.

Purpose of the Study:

  • To investigate the degree of endothelial, smooth muscle, and Schwann cell chimerism in human heart transplants.
  • To compare chimerism levels across different cell types and vessel sizes.

Main Methods:

  • Analysis of autopsy and endomyocardial biopsy specimens from heart transplant recipients.
  • Immunohistochemistry for endothelial (CD31), smooth muscle (alpha-actin), and Schwann (S-100) cells.
  • Y chromosome in situ hybridization to identify donor-derived cells in sex-mismatched transplants.

Main Results:

  • Endothelial cells exhibited the highest extracardiac chimerism (24.3%), followed by Schwann cells (11.2%) and vascular smooth muscle cells (3.4%).
  • Chimerism levels were significantly higher than previously observed for cardiomyocytes (0.04%).
  • High endothelial chimerism was detected as early as 1 month post-transplant and persisted up to 10 years, with greater prevalence in microcirculation.

Conclusions:

  • Extracardiac progenitor cells repopulate various heart cell types with differing frequencies.
  • Early recruitment of endothelial progenitors suggests a role for transplantation-related injury.
  • High endothelial chimerism may influence myocardial rejection and graft vasculopathy.
Abstract

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.